De Thaye

Monitoring cancer in the blood

Waiting for results after a medical examination often causes stress and uncertainty, especially in cancer patients. That is why Elien De Thaye is working on a method to determine the effect of a chemo treatment on people with peritoneal cancer more quickly on the basis of a so-called marker in the blood.

Are all those pills really needed as the end approaches?

Up to 91 pills a week. That's how many medicines people take at the end of their lives. Kristel Paque is investigating whether all these pills are really necessary.
Van Paemel

Liquid biopsies in cancer diagnosis

Did you know that 1 in 100 people who develop cancer are under 18 years of age? In order to diagnose cancer, a surgical biopsy is often required. But Ruben Van Paemel and his colleagues want to change this. They want to detect cancer in children by taking a simple blood sample.

Using computing power to fight cancer

Did you know that cancer researchers draw inspiration from applications such as Amazon, Facebook and even Tinder? Armed with a supercomputer, Celine Everaert, like these applications, processes large amounts of data. Not to sell books or to help people get on a date, but to offer cancer patients personalised treatments.
Ovia Margaret
KU Leuven

HER2 breast cancer: comprehend to conquer it!

Did you know that breast cancer is the second most common cancer for women, affecting 1.7 million women worldwide? In her research Ovia Margaret Thirukkumaran is trying to decipher how cancer cells communicate and develop resistance against drugs in so called HER 2 breast cancer, a very aggressive form of breast cancer.
KU Leuven

Let's no longer treat every ovarian cancer patient the same way

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.
KU Leuven

Chronic swallowing problems after head and neck cancer

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.
KU Leuven

Is the cure for cancer stuck in a jar?

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar
KU Leuven

Making immunotherapy stand up against colon cancer

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.
KU Leuven

Selecting the proper treatment for cancer patients

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.
KU Leuven

Organ transplants: life-saving, yet sometimes lethal

While an organ transplant will often save the life of a patient, it also leads to a higher risk of developing cancer. Nena Testelmans (KU Leuven) is determined to help unravel why transplants might induce cancer in patients.

Liver cancer: how do we get the medicines to the tumor?

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.